Table 4.
Baseline characteristics from individual fatty acid analysis
| Parameter | Optimally Healthy Controls (8) |
Metabolic Syndrome (7) |
P Value | Test |
|---|---|---|---|---|
| Demographic | ||||
| Age, yr | 45 (11) | 45 (7) | 0.87 | W |
| Sex (%male) | 4 (50%) | 5 (71%) | ||
| BMI | 23 (1) | 32 (4) | 0.0007 | W |
| Anti-hypertensive | 1 (14%) | |||
| Statin Use | . | |||
| Smoker | 1 (14%) | |||
| Vascular | ||||
| Heart rate, beats/min | 53 (7) | 68 (11) | 0.0096 | W |
| BP systolic, mmHg | 112 (7) | 139 (11) | 0.0002 | W |
| BP diastolic, mmHg | 70 (6) | 86 (8) | 0.0009 | W |
| Pulse pressure, mmHg | 44 (7) | 53 (13) | 0.13 | W |
| Mean arterial pressure, mmHg | 84 (8) | 103 (6) | 0.0001 | W |
| Glycemia | ||||
| Glucose, mmol/L | 4.8 (0.3) | 5.8 (0.9) | 0.027 | W |
| Insulin, μU/mL | 3 [3, 3] | 11 [5, 14] | 0.0015 | X2 |
| HOMA | 0.63 [0.59, 0.69] | 2.99 [1.28, 3.81] | 0.0017 | X2 |
| Lipemia | ||||
| Total cholesterol, mmol/L | 4.3 [3.8, 5.6] | 5.6 [3.5, 5.7] | 0.45 | X2 |
| HDL cholesterol, mmol/L | 1.6 (0.2) | 1.1 (0.2) | 0.0039 | W |
| LDL cholesterol, mmol/L | 2.6 (0.7) | 3.4 (1.0) | 0.23 | W |
| VLDL cholesterol, mmol/L | 0.39 [0.36, 0.47] | 0.62 [0.52, 0.75] | 0.0026 | X2 |
| Triglyceride, mmol/L | 0.78 (0.19) | 2.04 (0.58) | 0.0007 | W |
BP, blood pressure; BMI, body mass index; HOMA; homeostatic model assessment; W, Welch’s t test (assuming unequal variances), reported as means (SD); X2, Wilcoxon’s nonparametric test, reported as median [interquartile range]. Rows in boldface are significant at P < 0.05.